CapForce IBD Breakout Opportunities ETF (BOUT)
| Assets | $15.55M |
| Expense Ratio | 0.80% |
| PE Ratio | 20.67 |
| Shares Out | 350,000 |
| Dividend (ttm) | $0.12 |
| Dividend Yield | 0.28% |
| Ex-Dividend Date | Dec 31, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 5.82% |
| Volume | 473 |
| Open | 44.72 |
| Previous Close | 44.67 |
| Day's Range | 44.71 - 44.82 |
| 52-Week Low | 35.05 |
| 52-Week High | 49.41 |
| Beta | 1.04 |
| Holdings | 28 |
| Inception Date | Sep 13, 2018 |
About BOUT
Fund Home PageThe CapForce IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by CapForce.
Top 10 Holdings
62.96% of assets| Name | Symbol | Weight |
|---|---|---|
| U.S. Bancorp | USB | 7.35% |
| Enliven Therapeutics, Inc. | ELVN | 6.92% |
| Guardant Health, Inc. | GH | 6.83% |
| UroGen Pharma Ltd. | URGN | 6.34% |
| Kiniksa Pharmaceuticals International, plc | KNSA | 6.32% |
| The PNC Financial Services Group, Inc. | PNC | 6.25% |
| Ternium S.A. | TX | 6.22% |
| Bicara Therapeutics Inc. | BCAX | 6.07% |
| Tapestry, Inc. | TPR | 5.71% |
| Liquidia Corporation | LQDA | 4.94% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 31, 2025 | $0.1249 | Jan 2, 2026 |
| Dec 31, 2024 | $0.22753 | Jan 2, 2025 |
| Jul 31, 2024 | $0.0059 | Aug 1, 2024 |
| Dec 28, 2023 | $0.43704 | Jan 2, 2024 |
| Dec 29, 2022 | $0.39823 | Jan 3, 2023 |
| Dec 27, 2018 | $0.0389 | Jan 2, 2019 |
Performance
BOUT had a total return of 18.74% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.08%.
News
Capital-FORCE Welcomes IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs to New Rules-Based ETF Platform
LOS ANGELES--(BUSINESS WIRE)---- $BOUT #capforceetf--M2 Financial LLC, in conjunction with Capital-FORCE ETF Trust (“Capital-FORCE”), announced today the successful transition of the CapForce IBD® 50 ...
Capital-FORCE Enters ETF Market with Acquisition of Innovator IBD® 50 (FFTY) and IBD® Breakout Opportunities (BOUT) ETFs
LOS ANGELES--(BUSINESS WIRE)---- $BOUT #capforceetf--Capital-FORCE announced shareholder approval for the acquisition of Innovator IBD Breakout Opportunities ETF (BOUT) and Innovator IBD 50 ETF (FFTY)...
Innovator Announces Results of Special Meeting of Shareholders Relating to the Reorganizations of Innovator IBD® Breakout Opportunities ETF and Innovator IBD® 50 ETF
WHEATON, Ill., April 10, 2026 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (“Innovator”) announced today the results of the joint special meeting of shareholders of Innovator IBD® Breakout Op...